- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07575295
A Randomized Controlled Trial Comparing Underwater Versus Conventional Preventive Coagulation for Intraprocedural Vessel Management During Peroral Endoscopic Myotomy (POEM)
Peroral Endoscopic Myotomy (POEM) has become an established, minimally invasive therapy for achalasia and esophageal motility disorders. Submucosal tunnelling is a critical phase of POEM and requires meticulous haemostasis to avoid bleeding, loss of orientation, reduced visibility, and prolonged procedural time.
The current standard method of vessel coagulation during POEM involves conventional coagulation under CO₂ insufflation using the hybrid knife (HK). However, this approach can require additional hemostatic devices-most commonly coagulation forceps-particularly when dealing with large-calibre vessels or resistant bleeding.
A novel technique-underwater preventive coagulation-leverages water as a conductive medium. Preliminary evidence suggests that:
- electrosurgical current in water is focalized at the interface of the vessel,
- allowing a soft sealing of the vessel wall,
- reducing the risk of vessel rupture or unintended deep thermal injury,
- and potentially eliminating the need to convert to coagulation forceps. Pilot data from our center demonstrate that underwater prophylactic sealing of large vessels during POEM is feasible, safe, and associated with markedly reduced need for rescue coagulation forceps. The technique is already used in practice but lacks systematic evidence from prospective randomized trials.
This study is designed to provide high-quality evidence on whether underwater vessel coagulation improves haemostatic efficiency, reduces intra-procedural bleeding, and minimizes device changes during POEM.
All POEM procedures will be performed under general anesthesia in the supine position using Fujifilm high-definition gastroscopes with a 2.8 mm channel and transparent distal cap.
Steps (Both Arms)
- Identify the esophagogastric junction (EGJ).
- Inject saline + methylene blue submucosally.
- Create a 2 cm mucosal incision at 5-6 o'clock position, 10 cm above EGJ.
- Enter the submucosal space.
- Perform submucosal tunnelling down to EGJ and 2-3 cm into cardia.
Perform vessel haemostasis according to group allocation:
- Underwater coagulation (intervention)
- CO₂-based conventional coagulation (control)
- Perform circular myotomy (with occasional full-thickness myotomy when indicated).
- Close the mucosal entry using hemostatic clips.
- Record procedure time, instrument exchanges, bleeding events, and forceps usage.
Equipment
- Hybrid Knife (Erbe Elektromedizin GmbH)
- VIO 3 generator + ERBEJet 2 water-jet system
- Methylene-blue tinted saline
- Electrosurgical settings: ENDO CUT Q 2-3-3 for mucosal incision and myotomy
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
Primary Objective
To compare the proportion of POEM patients requiring rescue haemostasis with coagulation forceps (for active bleeding) between:
1. Underwater preventive vessel coagulation, and 2. Conventional vessel coagulation under CO₂ insufflation. Secondary Objectives
- To compare composite forceps use (rescue + prophylactic) between groups.
- To evaluate the frequency of prophylactic-only forceps use.
- To compare total number of forceps applications per procedure.
- To determine differences in intra-procedural bleeding episodes.
- To compare procedural efficiency (procedure time, number of instrument exchanges).
- To compare hematological and inflammatory markers (Hb drop, Hct, CRP, WBC).
- To compare delayed bleeding rates within 30 days.
- To evaluate overall complication rates (intra- and post-procedural).
- To assess patient-reported outcomes (pain, tolerability). A prospective, randomized, open-label, parallel-group, controlled clinical trial.
Study Arms Intervention Arm: Underwater Coagulation
- Vessel coagulation performed entirely underwater using the Hybrid Knife.
- SWIFT COAG: E3 (89 W) for POEM.
- Physiological saline instilled to completely displace air around the target vessel.
Control Arm: Conventional Coagulation (CO₂ Setting)
- Standard vessel isolation and coagulation under CO₂ insufflation.
- SWIFT COAG: E3 (89 W) for POEM.
Studietype
Inschrijving (Geschat)
Contacten en locaties
Studiecontact
- Naam: Rajesh Goud Mr Maragoni, M.Pharm
- Telefoonnummer: 312 04023378888
- E-mail: rajeshgoud761@gmail.com
Studie Contact Back-up
- Naam: Zaheer Nabi Dr Mohammed, MD DNB
- Telefoonnummer: 427 04023378888
- E-mail: zaheernabi1978@gmail.com
Studie Locaties
-
-
Telangana
-
Hyderabad, Telangana, Indië, 500082
- Werving
- Asian Institute of Gastroenterology Hospital
-
Contact:
- Mohan Ramchandani, MBBS
- Telefoonnummer: 802 04023378888
- E-mail: ramchandanimohan@gmail.com
-
Contact:
- Rajesh Goud Mr Maragoni, M.Pharm MBA
- Telefoonnummer: 301 04023378888
- E-mail: rajeshgoud761@gmail.com
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
- Age ≥ 18 years
- Diagnosis of achalasia or esophageal motility disorder planned for POEM
- Ability to provide informed consent
Exclusion Criteria:
- Anticoagulant or antithrombotic therapy not safely stoppable
- Known coagulopathy or platelet disorder
- Esophageal/gastric varices
- Previous POEM or Heller's myotomy
- Prior treatment for same condition
- Inability or refusal to consent
- Visualized vessels smaller than the HK inner diameter (1.2 mm)
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
Cohorten en interventies
Groep / Cohort |
Interventie / Behandeling |
|---|---|
|
Under Water Coagulation
Intervention Arm: Underwater Coagulation
|
Leverages water as a conductive medium. Preliminary evidence suggests that:
|
|
Conventional Coagulation
Control Arm: Conventional Coagulation (CO₂ Setting)
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
To compare the proportion of POEM patients requiring rescue haemostasis with coagulation forceps (for active bleeding) between:
Tijdsspanne: 60 minutes
|
|
60 minutes
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
To compare composite forceps use (rescue + prophylactic) between groups.
Tijdsspanne: 60 minutes
|
To compare the proportion of POEM patients requiring rescue haemostasis with coagulation forceps (for active bleeding) between: 1.Underwater preventive vessel coagulation, and Conventional vessel coagulation under CO₂ insufflation |
60 minutes
|
|
To evaluate the frequency of prophylactic-only forceps use.
Tijdsspanne: 60 minutes
|
To compare the proportion of POEM patients requiring rescue haemostasis with coagulation forceps (for active bleeding) between: 1.Underwater preventive vessel coagulation, and Conventional vessel coagulation under CO₂ insufflation |
60 minutes
|
|
To compare total number of forceps applications per procedure.
Tijdsspanne: 60 minutes
|
To compare the proportion of POEM patients requiring rescue haemostasis with coagulation forceps (for active bleeding) between: 1.Underwater preventive vessel coagulation, and Conventional vessel coagulation under CO₂ insufflation |
60 minutes
|
|
To determine differences in intra-procedural bleeding episodes
Tijdsspanne: 60 minutes
|
To compare the proportion of POEM patients requiring rescue haemostasis with coagulation forceps (for active bleeding) between: 1.Underwater preventive vessel coagulation, and Conventional vessel coagulation under CO₂ insufflation |
60 minutes
|
|
To compare procedural efficiency (procedure time, number of instrument exchanges
Tijdsspanne: 60 minutes
|
To compare the proportion of POEM patients requiring rescue haemostasis with coagulation forceps (for active bleeding) between: 1.Underwater preventive vessel coagulation, and Conventional vessel coagulation under CO₂ insufflation |
60 minutes
|
|
To compare hematological and inflammatory markers (Hb drop, Hct, CRP, WBC)
Tijdsspanne: 24 hours
|
To compare the proportion of POEM patients requiring rescue haemostasis with coagulation forceps (for active bleeding) between: 1.Underwater preventive vessel coagulation, and Conventional vessel coagulation under CO₂ insufflation |
24 hours
|
|
To compare delayed bleeding rates
Tijdsspanne: 30 days
|
To compare the proportion of POEM patients requiring rescue haemostasis with coagulation forceps (for active bleeding) between:1.Underwater preventive vessel coagulation, and Conventional vessel coagulation under CO₂ insufflation
|
30 days
|
|
To evaluate overall complication rates (intra- and post-procedural)
Tijdsspanne: 24 hours
|
To compare the proportion of POEM patients requiring rescue haemostasis with coagulation forceps (for active bleeding) between: 1.Underwater preventive vessel coagulation, and Conventional vessel coagulation under CO₂ insufflation |
24 hours
|
|
To assess patient-reported outcomes (pain, tolerability).
Tijdsspanne: 72 hours
|
To compare the proportion of POEM patients requiring rescue haemostasis with coagulation forceps (for active bleeding) between: 1.Underwater preventive vessel coagulation, and Conventional vessel coagulation under CO₂ insufflation |
72 hours
|
Medewerkers en onderzoekers
Onderzoekers
- Studie directeur: Mohan Dr Ramchandani, MD DM, Asian Institute of Gastroenterology
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Andere studie-ID-nummers
- POEM UWC 2026
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .